Pegfilgrastim is a granulocyte-colony stimulating ... It is administered as a subcutaneous injection once per chemotherapy cycle, at least 24 hours after cytotoxic chemotherapy.

In recent years, Cinfa Biotech used its resources to advance B12019, a biosimilar copy of Amgen’s chemotherapy-induced neutropenia drug Neulasta, through clinical trials. B12019 and Neulasta are ...

“As a single injection for each cycle of chemotherapy ... which supported its biosimilarity with Amgen’s Neulasta through a Phase I, randomised, assessor-blinded PK/PD study in healthy ...